Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 19 May, 2015
Eval/treat TG ≥500 mg/dL, unexplained ALT >3x ULN
By
vgreene
, 19 May, 2015
Fasting lipid panel, ALT, CK (if indicated)
By
vgreene
, 19 May, 2015
High-intensity statin5,6 + lifestyle [B]
By
vgreene
, 19 May, 2015
rosuvastatin 20 mg<sup>8</sup> daily
By
vgreene
, 19 May, 2015
atorvastatin 80 mg (or 40 mg)<sup>7</sup> daily
By
vgreene
, 19 May, 2015
Pre-statin eval
By
vgreene
, 19 May, 2015
+/- Eval for secondary causes/conditions that may influence statin safety
By
vgreene
, 19 May, 2015
Eval/treat TG ≥500 mg/dL, unexplained ALT >3x ULN
By
vgreene
, 19 May, 2015
Fasting lipid panel, ALT, CK (if indicated)
By
vgreene
, 19 May, 2015
Mod-intensity statin<sup>4</sup> + lifestyle [E]
Pagination
First page
Previous page
…
Page
3790
Page
3791
Page
3792
Page
3793
Current page
3794
Page
3795
Page
3796
Page
3797
Page
3798
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube
